500170-27-4

Usage

Uses

Used in Endocrinology:
(DEAMINO-CYS1,BETA-CYCLOHEXYL-ALA4,ARG8)-VASOPRESSIN is used as a therapeutic agent for treating diabetes insipidus, a condition characterized by excessive urination and thirst due to insufficient levels of antidiuretic hormone.
Used in Pediatric Urology:
In the pediatric field, (DEAMINO-CYS1,BETA-CYCLOHEXYL-ALA4,ARG8)-VASOPRESSIN is used as a treatment for bedwetting or nocturnal enuresis, helping to reduce the frequency of involuntary urination during sleep.
Used in Hematology:
(DEAMINO-CYS1,BETA-CYCLOHEXYL-ALA4,ARG8)-VASOPRESSIN is utilized as a hemostatic agent in certain bleeding disorders, particularly those involving platelet function or clotting factor deficiencies, by promoting the aggregation of platelets and the formation of blood clots.
Used in Pharmaceutical Formulations:
(DEAMINO-CYS1,BETA-CYCLOHEXYL-ALA4,ARG8)-VASOPRESSIN is used in the development of various pharmaceutical formulations such as nasal sprays, tablets, and injections, providing different administration routes for patients depending on the condition being treated and the physician's recommendations.

Upstream product

• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 4587-33-1 N-(tert-butyloxycarbonyl)-L-asparagine p-nitrophenyl ester 
• 5068-28-0 (2R)-3-benzylsulfanyl-2-tert-butoxycarbonylamino-propionic acid 
• 13836-37-8 Boc-Arg(Tos)-OH 

Relevant academic research and scientific papers

Design and synthesis of the first selective agonists for the rat vasopressin V1b receptor: Based on modifications of deamino-[cys 1]arginine vasopressin at positions 4 and 8

The neurohypophyseal peptides arginine vasopressin (AVP) and oxytocin (OT) mediate a wide variety of peripheral and central physiological and behavioral effects by acting on four different G-protein coupled receptors, termed V 1a (vascular), V